{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11385886", "DateCompleted": {"Year": "2001", "Month": "06", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1462-3935", "JournalIssue": {"Volume": "62", "Issue": "5", "PubDate": {"Year": "2001", "Month": "May"}}, "Title": "Hospital medicine (London, England : 1998)", "ISOAbbreviation": "Hosp Med"}, "ArticleTitle": "St John's wort for depression: what's the evidence?", "Pagination": {"StartPage": "274", "EndPage": "276", "MedlinePgn": "274-6"}, "Abstract": {"AbstractText": ["There is a moderate amount of evidence to suggest that St John's wort is better than placebo in the short-term management of mild to moderate depressive illness, but there is increasing concern over reports of drug interactions. This article examines the scientific evidence and discusses relevant clinical issues."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Stanley Research Centre Ireland, St John of God Hospital, Stillorgan, Dublin, Ireland."}], "Identifier": [], "LastName": "Kelly", "ForeName": "B D", "Initials": "BD"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Hosp Med", "NlmUniqueID": "9803882", "ISSNLinking": "1462-3935"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Dopamine Uptake Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Serotonin Uptake Inhibitors"}], "MeshHeadingList": [{"QualifierName": ["therapy"], "DescriptorName": "Depression"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Dopamine Uptake Inhibitors"}, {"QualifierName": [], "DescriptorName": "Drug Interactions"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Randomized Controlled Trials as Topic"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Selective Serotonin Reuptake Inhibitors"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}], "NumberOfReferences": "23"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "6", "Day": "2", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "6", "Day": "22", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "6", "Day": "2", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11385886", "10.12968/hosp.2001.62.5.1569"]}}], "PubmedBookArticle": []}